Authors:
OUADAHI S
PATERNOSTRE M
ANDRE C
GENIN I
THAO TX
PUISIEUX F
DEVISSAGUET JP
BARRATT G
Citation: S. Ouadahi et al., LIPOSOMAL FORMULATIONS FOR ORAL IMMUNOTHERAPY - IN-VITRO STABILITY INSYNTHETIC INTESTINAL MEDIA AND IN-VIVO EFFICACY IN THE MOUSE, Journal of drug targeting, 5(5), 1998, pp. 365-378
Authors:
PASSIRANI C
BARRATT G
DEVISSAGUET JP
LABARRE D
Citation: C. Passirani et al., LONG-CIRCULATING NANOPARTICLES BEARING HEPARIN OR DEXTRAN COVALENTLY BOUND TO POLY(METHYL METHACRYLATE), Pharmaceutical research, 15(7), 1998, pp. 1046-1050
Authors:
PASSIRANI C
BARRATT G
DEVISSAGUET JP
LABARRE D
Citation: C. Passirani et al., INTERACTIONS OF NANOPARTICLES BEARING HEPARIN OR DEXTRAN COVALENTLY BOUND TO POLY(METHYL METHACRYLATE) WITH THE COMPLEMENT-SYSTEM, Life sciences, 62(8), 1998, pp. 775-785
Authors:
SEYLER I
APPEL M
DEVISSAGUET JP
LEGRAND P
BARRATT G
Citation: I. Seyler et al., MODULATION OF NITRIC-OXIDE PRODUCTION IN RAW-264.7 CELLS BY TRANSFORMING GROWTH-FACTOR-BETA AND INTERLEUKIN-10 - DIFFERENTIAL-EFFECTS ON FREE AND ENCAPSULATED IMMUNOMODULATOR, Journal of leukocyte biology, 62(3), 1997, pp. 374-380
Authors:
ESPUELAS MS
LEGRAND P
IRACHE JM
GAMAZO C
ORECCHIONI AM
DEVISSAGUET JP
YGARTUA P
Citation: Ms. Espuelas et al., POLY(EPSILON-CAPROLACTON) NANOSPHERES AS AN ALTERNATIVE WAY TO REDUCEAMPHOTERICIN-B TOXICITY, International journal of pharmaceutics, 158(1), 1997, pp. 19-27
Authors:
FAWAZ F
GUYOT M
LAGUENY AM
DEVISSAGUET JP
Citation: F. Fawaz et al., CIPROFLEXACIN-LOADED POLYISOBUTYLCYANOACRYLATE NANOPARTICLES - PREPARATION AND CHARACTERIZATION, International journal of pharmaceutics, 154(2), 1997, pp. 191-203
Authors:
THIOUNE O
FESSI H
DEVISSAGUET JP
PUISIEUX F
Citation: O. Thioune et al., PREPARATION OF PSEUDOLATEX BY NANOPRECIPITATION - INFLUENCE OF THE SOLVENT NATURE ON INTRINSIC-VISCOSITY AND INTERACTION CONSTANT, International journal of pharmaceutics, 146(2), 1997, pp. 233-238
Authors:
DOEGITO EST
FESSI H
APPEL M
BARRATT G
LEGRAND P
BOLARD J
DEVISSAGUET JP
Citation: Est. Doegito et al., A MORPHOLOGICAL-STUDY OF AN AMPHOTERICIN-B EMULSION-BASED DELIVERY SYSTEM, International journal of pharmaceutics, 145(1-2), 1996, pp. 17-27
Citation: V. Masson et al., STABILITY OF POLY (EPSILON-CAPROLACTON) NANOSPHERES IN STERILE AQUEOUS-MEDIA, International journal of pharmaceutics, 139(1-2), 1996, pp. 113-123
Authors:
BELBELLA A
VAUTHIER C
FESSI H
DEVISSAGUET JP
PUISIEUX F
Citation: A. Belbella et al., IN-VITRO DEGRADATION OF NANOSPHERES FROM POLY(D,L-LACTIDES) OF DIFFERENT MOLECULAR-WEIGHTS AND POLYDISPERSITIES, International journal of pharmaceutics, 129(1-2), 1996, pp. 95-102
Authors:
DOEGITO EST
APPEL M
FESSI H
BARRATT G
PUISIEUX F
DEVISSAGUET JP
Citation: Est. Doegito et al., IN-VITRO AND IN-VIVO EVALUATION OF A NEW AMPBOTERICIN-B EMULSION-BASED DELIVERY SYSTEM, Journal of antimicrobial chemotherapy, 38(3), 1996, pp. 485-497
Authors:
DECHASTEIGNER S
CAVE G
FESSI H
DEVISSAGUET JP
PUISIEUX F
Citation: S. Dechasteigner et al., FREEZE-DRYING OF ITRACONAZOLE-LOADED NANOSPHERE SUSPENSIONS - A FEASIBILITY STUDY, Drug development research, 38(2), 1996, pp. 116-124
Authors:
DECHASTEIGNER S
FESSI H
DEVISSAGUET JP
PUISIEUX F
Citation: S. Dechasteigner et al., COMPARATIVE-STUDY OF THE ASSOCIATION OF ITRACONAZOLE WITH COLLOIDAL DRUG CARRIERS, Drug development research, 38(2), 1996, pp. 125-133
Authors:
SEYLER I
APPEL M
DEVISSAGUET JP
LEGRAND P
BARRATT G
Citation: I. Seyler et al., RELATIONSHIP BETWEEN NO-SYNTHASE ACTIVITY AND TNF-ALPHA SECRETION IN MOUSE MACROPHAGE LINES STIMULATED BY A MURAMYL PEPTIDE ENTRAPPED IN NANOCAPSULES, International journal of immunopharmacology, 18(6-7), 1996, pp. 385-392
Authors:
MERHI G
COLEMAN AW
DEVISSAGUET JP
BARRATT GM
Citation: G. Merhi et al., SYNTHESIS AND IMMUNOSTIMULATING PROPERTIES OF LIPOPHILIC ESTER AND ETHER MURAMYL PEPTIDE DERIVATIVES, Journal of medicinal chemistry, 39(22), 1996, pp. 4483-4488
Authors:
THIOUNE O
FESSI H
WOUESSIDJEWE D
DEVISSAGUET JP
PUISIEUX F
Citation: O. Thioune et al., HYDROXYPROPYLMETHYL CELLULOSE PHTHALATE AQUEOUS DISPERSION FOR COATING - PREPARATION BY A NANOPRECIPITATION METHOD, STP pharma sciences, 5(5), 1995, pp. 367-372
Authors:
DECHASTEIGNER S
FESSI H
CAVE G
DEVISSAGUET JP
PUISIEUX F
Citation: S. Dechasteigner et al., GASTROINTESTINAL TOLERANCE STUDY OF A FREEZE-DRIED ORAL DOSAGE FORM OF INDOMETHACIN-LOADED NANOCAPSULES, STP pharma sciences, 5(3), 1995, pp. 242-246
Authors:
RODRIGUES JM
FESSI H
BORIES C
PUISIEUX F
DEVISSAGUET JP
Citation: Jm. Rodrigues et al., PRIMAQUINE-LOADED POLY(LACTIDE) NANOPARTICLES - PHYSICOCHEMICAL STUDYAND ACUTE TOLERANCE IN MICE, International journal of pharmaceutics, 126(1-2), 1995, pp. 253-260
Authors:
GUTERRES SS
FESSI H
BARRATT G
DEVISSAGUET JP
PUISIEUX F
Citation: Ss. Guterres et al., POLY(DL-LACTIDE) NANOCAPSULES CONTAINING DICLOFENAC .1. FORMULATION AND STABILITY STUDY, International journal of pharmaceutics, 113(1), 1995, pp. 57-63
Authors:
GUTERRES SS
FESSI H
BARRATT G
DEVISSAGUET JP
PUISIEUX F
Citation: Ss. Guterres et al., POLY(DL-LACTIDE) NANOCAPSULES CONTAINING DICLOFENAC .1. FORMULATION AND STABILITY STUDY, International journal of pharmaceutics, 113(1), 1995, pp. 57-63
Authors:
DELABOURET A
THIOUNE O
FESSI H
DEVISSAGUET JP
PUISIEUX F
Citation: A. Delabouret et al., APPLICATION OF AN ORIGINAL PROCESS FOR OBTAINING COLLOIDAL DISPERSIONS OF SOME COATING POLYMERS - PREPARATION, CHARACTERIZATION, INDUSTRIALSCALE-UP, Drug development and industrial pharmacy, 21(2), 1995, pp. 229-241
Authors:
MESTIRI M
BENOIT JP
HERNIGOU P
DEVISSAGUET JP
PUISIEUX F
Citation: M. Mestiri et al., CISPLATIN-LOADED POLY(METHYL METHACRYLATE) IMPLANTS - A SUSTAINED DRUG-DELIVERY SYSTEM, Journal of controlled release, 33(1), 1995, pp. 107-113
Authors:
RODRIGUES JM
BORIES C
EMERY I
FESSI H
DEVISSAGUET JP
LIANCE M
Citation: Jm. Rodrigues et al., DEVELOPMENT OF AN INJECTABLE FORMULATION OF ALBENDAZOLE AND IN-VIVO EVALUATION OF ITS EFFICACY AGAINST ECHINOCOCCUS-MULTILOCULARIS METACESTODE, International journal for parasitology, 25(12), 1995, pp. 1437-1441